Delivery Order SPE2DB24D1021-SPE2DB25FEYZD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,500.75 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine vials on September 10, 2025. This competitively awarded, firm fixed-price contract carries a ceiling value of $2,286.87 and has an ultimate completion date of September 11, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,376.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of IMOVAX Rabies Vaccine vials. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), requires completion by July 28, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,924.74 on August 29, 2025, for the supply of IMOVAX Rabies Vaccine Vials. The contract is competitively awarded with no set-aside designation and employs firm fixed price terms, with an ultimate completion date of September 2, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,568.75 for IMOVAX Rabies Vaccine vials on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,227.50 delivery order for IMOVAX Rabies Vaccine vials under a firm fixed-price contract type. This non-set-aside award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,895.75 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. The contract, which was competitively awarded with no set-aside designation, is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of IMOVAX Rabies Vaccine Vials with a ceiling value of $12,591.13 under a firm fixed-price contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award was made without a set-aside designation, indicating it was competitively awarded. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,032.44 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. This firm fixed price contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a routine medical supply procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,341.25 to AmerisourceBergen Drug Corp for Imovax Rabies Vaccine vials on August 28, 2025, with a completion date of August 29, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYZDDelivery Order
The Defense Logistics Agency awarded a Delivery Order valued at $4,315.56 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials, with a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract reflects DLA's ongoing pharmaceutical procurement needs to support military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime vendor in DLA's global pharmaceutical support program, AmerisourceBergen supplies an extensive range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare customers worldwide. The company's capability to deliver specialized medical commodities such as rabies vaccines demonstrates its critical role in maintaining the medical supply chain for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/28/25 |